Philip Kuhlman

Philip Kuhlman has a diverse work experience spanning over several industries. Philip is currently working as the Head of Analytical Development at Touchlight, a position they started in February 2022. Prior to this, they served as the Analytical Development Team Lead at The Vaccines Manufacturing and Innovation Centre (VMIC UK) from November 2020 to February 2022.

Before their role at VMIC UK, Philip worked at Reading Scientific Services Ltd (RSSL) for a significant period. Philip held the position of Associate Principal Scientist from May 2016 to November 2020. Prior to that, they were a Senior Scientist focused on DNA and Protein research from November 2013 to May 2016.

Prior to working at RSSL, Philip worked as a CGA Alberta at The Certified General Accountants Association of Alberta (CGA Alberta) from September 2012 to July 2013. Philip also gained experience as a Guest Services Representative at Cardel Place from May 2012 to July 2013, where they provided customer services and support to the accounting department.

Furthermore, Philip served as a Senior Research Scientist/Project Leader at Sembiosys Genetics Inc from June 2005 to March 2012. Philip played a vital role in the insulin program, focusing on the cost-effective production of human insulin in plants.

Earlier in their career, Philip worked as a Senior Scientist at Isogenica Ltd from January 2001 to May 2005. Philip was involved in the production and screening of peptide libraries.

Philip's work experience also includes a Wellcome Trust Career Development Fellowship from January 1997 to January 2001. During this time, they conducted research on actin filament length determination and maintenance using the human erythrocyte as a model system.

Their early research experience includes a role as a Research Associate at the University of Leicester from 1995 to 1997, where they worked on studying muscle protein myosin. Philip also served as a Research Associate at The Scripps Research Institute from December 1993 to an unspecified date in 1995, focusing on proteins controlling actin filament length and regulation.

Overall, Philip Kuhlman has extensive experience in analytical development, protein research, and project leadership, with a particular focus on the pharmaceutical and scientific research industries.

Philip Kuhlman obtained their Ph.D. in Biochemistry from the University of Leicester, which they pursued from 1990 to 1993. Prior to that, they completed their Bachelor of Science degree in Biochemistry and Biotechnology from the University of Birmingham, where they attended from 1987 to 1990. Later, in the period of 2012 to 2015, they studied Accounting at Athabasca University, however, the specific degree obtained during this time is not provided.